Seventy-three percent of patients with breast and other solid tumors did not experience ILD recurrence when rechallenged with ...

Researchers at ASCO's annual meeting also discussed the importance of repeat biopsies to assess HER2 status after first-line ...

Positive new data suggests that more people facing advanced breast cancer may be able to put off treatment with harsh ...

The strong oncology performance is being driven by medicines such as Tagrisso, Merck-partnered Lynparza, Imfinzi, Calquence and Daiichi Sankyo-partnered Enhertu ... seen in the chart below.

One of these studies is looking at ELVN-002 in combination with AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu as a treatment for HER2-positive breast cancer. The other study ...

Health and Human Services Secretary Robert F. Kennedy Jr. has made combating chronic disease a rallying cry as he looks to overhaul the health department and “Make America Healthy Again.” So ...

One intervention has consistently stood out and, in the case of Louisiana and the District of Columbia, has been a pillar of their pandemic-recovery plan: high-dosage tutoring, also known as high ...

Your doctor will calculate your Trodelvy dosage using your body weight in kilograms (kg). For reference, 1 kg is about 2.2 pounds (lb). The recommended Trodelvy dose for treating breast cancer is ...

If people decide to stop taking hormone therapy, they should reduce the dosage gradually. Stopping abruptly may cause a return of menopause symptoms, such as hot flashes and disrupted sleep.

Both trastuzumab deruxtecan (T-DXd; Enhertu) monotherapy and T-DXd plus pertuzumab (Perjeta ... André reported on an interim analysis of the part 2 dose-expansion phase for the T-DXd monotherapy arm ...

Dixie Villa received the maximum sentence for manslaughter following the February 2019 death of Abigail Lobisch, per local media reports Becca Longmire is a digital news writer-reporter at PEOPLE ...